Non-Brain Diseases Fuel Dementia Surge

A medical professional holding a glowing digital brain illustration in their hand

Gum disease tops the list of non-brain conditions driving one-third of all dementia cases worldwide.

Story Snapshot

Sun Yat-sen University researchers analyzed over 200 studies on 26 peripheral diseases, linking 16 to dementia.
These conditions account for 33.18% of global dementia burden, affecting about 18.8 million cases.
Top contributors: periodontal disease, chronic liver diseases, hearing loss, vision loss, and type 2 diabetes.
Prevention through managing these diseases could slash millions of cases, shifting focus from brain-only risks.

Sun Yat-sen Study Reveals Peripheral Disease Links

Researchers at Sun Yat-sen University, led by Deng and Yang, conducted a systematic review and meta-analyses of data from more than 200 global studies. They examined 26 non-brain diseases. Sixteen showed significant associations with increased dementia risk. The population attributable fraction reached 33.18%, with a 95% confidence interval of 16.80–48.43. This equates to roughly 18.8 million prevalent cases worldwide. The analysis excluded brain-direct factors, honing in on peripheral impacts.

Top Five Peripheral Contributors Ranked

Periodontal disease led with the highest contribution at 3.46% PAF. Chronic liver diseases followed closely. Hearing loss ranked third, impairing cognition through sensory deprivation. Vision loss came fourth, linked via similar pathways. Type 2 diabetes mellitus rounded out the top five, fueling vascular and metabolic damage. These conditions operate through inflammation, vascular harm, and organ-brain connections. Ten of the 26 diseases, including hypertension, showed no significant links.

Evolution from Lancet Commission Reports

The 2020 Lancet Commission identified nine modifiable risks preventing about 35% of dementia cases, including hearing loss and diabetes. The 2024 update expanded to 14 factors, estimating 45% preventable, adding vision loss and high cholesterol. Sun Yat-sen study distinguishes by quantifying only non-brain diseases at 33% PAF. It aligns on overlaps like sensory losses but notes weaker evidence for hypertension and obesity compared to Lancet. This peripheral focus complements lifestyle emphases.

Global dementia burdens aging populations, especially in low- and middle-income countries with high rates of these diseases. Peripheral conditions like diabetes and hearing loss trigger inflammation and vascular damage affecting brain health.

Public Health and Prevention Strategies

Authors call for targeted interventions on the 16 diseases. Short-term shifts include routine dental care, diabetes management, and sensory screenings. Long-term prevention could delay onset and reduce 18.8 million cases. Economic savings arise from lower healthcare costs. Social benefits ease caregiver burdens. Political policies, informed by this data, promote proactive health like the Lancet recommendations.

Stakeholders include Sun Yat-sen team driving evidence, Nature Human Behaviour amplifying findings, and Lancet experts shaping consensus. Public health policymakers and Alzheimer’s societies influence implementation. No conflicts noted; motivations center on prevention. The study establishes associations, not causality—reverse causation remains possible, as with depression. Wide confidence intervals reflect data heterogeneity, underscoring need for further research.